NCT06224673 2026-02-13ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerUniversity of California, San FranciscoPhase 2 Not yet recruiting36 enrolled
NCT06578286 2024-08-29ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXdFudan UniversityPhase 2 Not yet recruiting44 enrolled